Dominik Lock

537 total citations
18 papers, 288 citations indexed

About

Dominik Lock is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Dominik Lock has authored 18 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Biomedical Engineering. Recurrent topics in Dominik Lock's work include CAR-T cell therapy research (16 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Virus-based gene therapy research (5 papers). Dominik Lock is often cited by papers focused on CAR-T cell therapy research (16 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Virus-based gene therapy research (5 papers). Dominik Lock collaborates with scholars based in Germany, Netherlands and Switzerland. Dominik Lock's co-authors include Andrew Kaiser, Thomas Schaser, Mario Assenmacher, Wa’el Al Rawashdeh, Olaf Hardt, Daniela Mauer, Peter Borchmann, Udo Holtick, Natali Pflug and Nadine Mockel-Tenbrinck and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Dominik Lock

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominik Lock Germany 9 236 119 104 87 77 18 288
Christian Flugel Germany 3 292 1.2× 108 0.9× 126 1.2× 115 1.3× 69 0.9× 4 341
Wengang Ge China 5 193 0.8× 116 1.0× 52 0.5× 63 0.7× 81 1.1× 7 252
Lisa S. Rolczynski United States 5 253 1.1× 103 0.9× 128 1.2× 105 1.2× 79 1.0× 5 328
Nancy P. Kren United States 7 255 1.1× 79 0.7× 167 1.6× 83 1.0× 53 0.7× 7 338
Minnal Gupta United States 7 255 1.1× 97 0.8× 84 0.8× 73 0.8× 114 1.5× 9 309
Leila Jafarzadeh Iran 11 266 1.1× 170 1.4× 141 1.4× 81 0.9× 88 1.1× 18 393
Nils Wellhausen United States 7 213 0.9× 117 1.0× 87 0.8× 50 0.6× 76 1.0× 14 273
Sara Silbert United States 5 224 0.9× 78 0.7× 69 0.7× 73 0.8× 44 0.6× 17 257
Shiwani Agarwal Germany 7 273 1.2× 135 1.1× 158 1.5× 86 1.0× 124 1.6× 7 359

Countries citing papers authored by Dominik Lock

Since Specialization
Citations

This map shows the geographic impact of Dominik Lock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Lock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Lock more than expected).

Fields of papers citing papers by Dominik Lock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Lock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Lock. The network helps show where Dominik Lock may publish in the future.

Co-authorship network of co-authors of Dominik Lock

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Lock. A scholar is included among the top collaborators of Dominik Lock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Lock. Dominik Lock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Lock, Dominik, Boris Engels, Mario Assenmacher, et al.. (2025). A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo. Molecular Therapy — Methods & Clinical Development. 33(3). 101526–101526.
3.
Hageman, Lois, Marieke Griffioen, Nadine Mockel-Tenbrinck, et al.. (2024). Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy. Molecular Therapy — Methods & Clinical Development. 32(2). 101224–101224. 2 indexed citations
4.
Engels, Boris, et al.. (2024). CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment. SHILAP Revista de lepidopterología. 32(2). 200797–200797. 13 indexed citations
5.
Rawashdeh, Wa’el Al, Dominik Lock, Christoph Herbel, et al.. (2023). Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice. International Journal of Molecular Sciences. 24(11). 9184–9184. 7 indexed citations
6.
Kaiser, Andrew, et al.. (2023). Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma. Frontiers in Immunology. 14. 1178060–1178060. 5 indexed citations
7.
Wang, Xueting, et al.. (2022). Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”. International Journal of Molecular Sciences. 23(23). 14563–14563. 11 indexed citations
8.
Lock, Dominik, Razieh Monjezi, Marco Schmeer, et al.. (2022). Automated, scaled, transposon-based production of CAR T cells. Journal for ImmunoTherapy of Cancer. 10(9). e005189–e005189. 33 indexed citations
9.
Krueger, Winfried, André Roy, Wa’el Al Rawashdeh, et al.. (2021). Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors. Cancers. 13(19). 4741–4741. 13 indexed citations
10.
Lock, Dominik, Franziska Blaeschke, Sandra Karitzky, et al.. (2021). Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Molecular Therapy — Methods & Clinical Development. 21. 42–53. 10 indexed citations
11.
Alzubi, Jamal, Dominik Lock, Manuel Rhiel, et al.. (2020). Automated generation of gene-edited CAR T cells at clinical scale. Molecular Therapy — Methods & Clinical Development. 20. 379–388. 41 indexed citations
12.
Lock, Dominik, et al.. (2020). StraightFrom®MicroBeads: Fast T cell isolation for CAR T cell manufacturing without density gradient centrifugation. The Journal of Immunology. 204(1_Supplement). 86.28–86.28. 1 indexed citations
13.
Seitz, Christian, Stefan Grote, Dominik Lock, et al.. (2018). Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles. Blood. 132(Supplement 1). 4543–4543. 8 indexed citations
14.
Nowak, A, Dominik Lock, Petra Bächer, et al.. (2018). CD137+CD154− Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures. Frontiers in Immunology. 9. 199–199. 50 indexed citations
15.
Seitz, Christian, Patrick Schlegel, Sarah M. Schroeder, et al.. (2017). Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens. Blood. 130. 1912–1912. 3 indexed citations
16.
Lock, Dominik, Nadine Mockel-Tenbrinck, Daniela Mauer, et al.. (2017). Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Human Gene Therapy. 28(10). 914–925. 85 indexed citations
17.
Lock, Dominik, et al.. (2016). 653. Sialyl Glycolipid Stage-Specific Embryonic Antigen 4 (SSEA4) - A Novel Target for CAR T Cell Therapy of Solid Cancers. Molecular Therapy. 24. S259–S259. 5 indexed citations
18.
Schambach, Axel, Dominik Lock, Dirk Wedekind, et al.. (2014). FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells. PLoS ONE. 9(7). e102171–e102171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026